One Gene, Two Mutations

Knocking down a single gene spurs pronounced secondary effects in the yeast genome.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, ZEISS MICROSCOPYResearchers had long suspected that silencing one gene could cause secondary effects elsewhere in the genome. But just how widespread these “secondary mutations” are was largely left to conjecture. Now, a team led by investigators at the Johns Hopkins University School of Medicine in Baltimore, Maryland, has shown that perturbation of any single gene in the yeast genome is sufficient to drive subsequent genetic changes. The team’s results were published today (November 5) in Molecular Cell.

“Certainly people had seen secondary mutations before in these yeast strains, but I think what’s special is the prevalence of them,” said Stanford University’s Michael Snyder, who was not involved in the work. The study, he added, shows that “a very large number of knockouts have a secondary mutation—much higher than I would have guessed.”

J. Marie Hardwick and her colleagues were exploring cell death mechanisms in yeast when they first noticed genomic variability among cells of Saccharomyces cerevisiae knockout strains. Comparing cells derived from the caf4-deletion strain, Xinchen Teng—then a postdoc in Hardwick’s lab and now an associate professor at Soochow University in China—first ruled out contamination or incorrect knockout construction as potential sources of the variation. Further tests showed that stochastic fluctuations in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies